Treatment of intraventricular hemorrhage with tissue plasminogen activator.
The patients with intraventricular hemorrhage (IVH) were treated with recombinant tissue plasminogen activator (rt-PA) injected directly into the lateral ventricles, followed by ventricular drainage. All had a decreased level of consciousness before treatment (Glasgow Coma Scale score 10 +/- 3.4). A total dose between 2 and 12 mg of rt-PA (6.4 +/- 3.3) was administered. For eight patients with aneurysmal IVH, treatment with rt-PA began with two patients the same day as the aneurysm clipping, and the day after with six patients. For a patient with an excision of a ruptured arteriovenous malformation and a patient with IVH resulting from a lateral ventricular catheterization during posterior fossa tumor surgery, treatment with rt-PA started 24 hours after surgery. After an injection of rt-PA, the ventricular drain was closed for 1 hour, followed by alternate-hourly drainage and intracranial pressure (ICP) monitoring. Five patients received a second injection of rt-PA on the second postoperative day, and one patient received a third dose on the third day. Among the eight patients given rt-PA the day after surgery, the volume of external cerebrospinal fluid (CSF) drainage for 24 +/- 8 hours before treatment was 61 +/- 57 ml, and the mean ICP was 22 +/- 5 mm Hg during this same time. Younger age and poorer neurological condition correlated with higher ICP before treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
Findlay
J M
JM
Division of Neurosurgery, University of Alberta, Edmonton, Canada.
Grace
M G
MG
Weir
B K
BK
D000293:Adolescent; D000368:Aged; D002543:Cerebral Hemorrhage / Q000000981:diagnostic imaging / Q000628:therapy*; D002552:Cerebral Ventricles / Q000187:drug effects; D002557:Cerebrospinal Fluid Shunts; D005260:Female; D006801:Humans; D007276:Injections, Intraventricular; D002532:Intracranial Aneurysm / Q000000981:diagnostic imaging / Q000601:surgery; D007427:Intracranial Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000000981:diagnostic imaging / Q000628:therapy; D011994:Recombinant Proteins / Q000008:administration & dosage; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator